PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Design of experiments in optimization and validation of hydrophilic interaction liquid chromatography method for determination of amlodipine besylate and its impurities

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A new and rapid hydrophilic interaction liquid chromatographic method has been developed for the quantitative analysis of amlodipine besylate and its specific impurities (D, E, and F). For development of this method, a systematic approach which includes Design of Experiments methodology was applied. For the method optimization, Box–Behnken design and specific way Derringer’s desirability function were applied. They provided identification of the optimal chromatographic conditions on the basis of obtained mathematical models and graphical procedures (three D graphs). The optimal chromatographic conditions were the analytical column ZORBAX NH2 (250 3 4.6 mm, 5 mm particle size); mobile phase consisted of acetonitrile-water phase (50 mM ammonium acetate, pH adjusted to 4.0 with glacial acetic acid) (90.5:9.5 v/v); column temperature 30 8C, mobile phase flow rate 1 mL min1, wavelength of detection 230 nm. As other validation parameters were also found to be suitable, the possibility to apply the proposed method for the determination of amlodipine besylate and its impurities in any laboratory under different circumstances has been proven.
Rocznik
Strony
41--52
Opis fizyczny
Bibliogr. 25 poz., rys., tab.
Twórcy
  • Department of Pharmacy, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina
  • Department of Pharmacy, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina
Bibliografia
  • 1. Brereton, R. G. Chemometrics – Data Analysis for the Laboratory and Chemical Plant. John Wiley & Sons Ltd, The Atrium: Chichester, 2003, pp 1–19.
  • 2. Massart, D. L.; Vandeginste, B. G. M.; Buydens, L. M. C.; De Jong, S.; Lew, P. J.; Smeyers–Verbeke, J. Handbook of Chemometrics and Qualimetrics: Part A. Elsevier: Amsterdam, 1997, pp 121–51.
  • 3. Massart, D. L.; Vandeginste, B. G. M.; Deming, S. N.; Michotte, Y.; Kaufman, L. Chemometrics: A Textbook, Eslevier Science Publishers BV: Amsterdam, 2003, pp 5–10.
  • 4. Araujo, P. W.; Brereton, R. G. Trends. Anal. Chem. 1996, 15, 63–70. https://doi.org/10.1016/0165-9936(96)80762-X.
  • 5. Rayan, T. P. Modern Experimental Design; John Wiley & Sons Inc: Hoboken, New Jersey, 2007, pp 13–8.
  • 6. Amstrong, N. A. Pharmaceutical Experimental Design and Interpretation; Taylor & Francis Group: Boca Raton, USA, 2006, pp 41–52.
  • 7. Ferreira, S. L. C.; Bruns, R. E.; Da Silva, E. G. P.; Dos Santos, W. N. L.; Quintella, C. M.; David, J. M.; De Andrade, J. B.; Breitkreitz, M. C.; Jardim, I. C. S. F.; Neto, B. B. J. Chromatogr. A. 2007, 1158, 2–14. https://doi.org/10.1016/j.chroma.2007.03.051.
  • 8. Safa, F.; Hadjmohammadi, M. R. J. Chromatogr. A. 2005, 1078, 42–50. https://doi.org/10.1016/j.chroma.2005.04.081.
  • 9. Sivakumar, T.; Manavalan, R.; Valliappan, K. Acta. Chromatogr. 2007, 19, 29– 47. https://pdfs.semanticscholar.org/2725/235f8e8fe39d4b780d16bb32fd1bab4d706b.pdf.
  • 10. D’Hondt, M.; Verbeke, F.; Stalmans, S.; Gevaert, B.; Wynendaele, E.; De Spiegeleer, B. J. Pharm. Analysis. 2014, 4, 173–82. https://doi.org/10.1016/j.jpha.2013.09.001.
  • 11. Jeong, I. J.; Kim, K. J. Eur. J. Oper. Res. 2009, 195, 412–26. https://doi.org/10.1016/j.ejor.2008.02.018.
  • 12. Sivakumar, T.; Manavalant, R.; Muralidharan, C.; Valliappan, K. J. Pharm. Biomed. Anal. 2007, 43, 1842–8. https://doi.org/10.1016/j.jpba.2006.12.007.
  • 13. Buszewski, B.; Noga, S. Anal. Bioanal. Chem. 2012, 402, 231–47. https://dx.doi.org/10.1007%2Fs00216-011-5308-5.
  • 14. Rang, H. P.; Ritter, J. M.; Flower, R. J.; Henderson, G. Rang and Dale’s Pharmacology, 8th ed.; Churchill Livingstone: London, 2015,p 265.
  • 15. European Pharmacopoeia 9th ed.; European Directorate for the Quality of Medicines and HealthCare (EDQM & HealthCare), Council of Europe: Strasbourg, France, 2017, p 1547.
  • 16. Dai, S. Y.; Qiu, S. T.; Wu, W.; Fu, C. M. J. Pharm. Anal. 2013, 3, 440–6. https://doi.org/10.1016/j.jpha.2013.09.002.
  • 17. Jaivik, V. S.; Jignesh M. P.; Priyanka, A. S.; Priya, V. S.; Mallika, S. ; Pranav, S. S. J. Pharm. Anal. 2017, 7, 309–16. https://doi.org/10.1016/j.jpha.2017.06.001.
  • 18. Vojta, J. ; Jedlička, A. ; Coufal, P. ; Janečkova, L. J. Pharm. Biomed. Anal. 2015, 109, 36–44. https://doi.org/10.1016/j.jpba.2015.01.059.
  • 19. Sangeetha, D.; Vadlamudi, M. K. J. Liq. Chromatogr. Relat. Technol. 2017, 40, 576–98. https://doi.org/10.1080/10826076.2017.1334215.
  • 20. El-Bagary, R. I.; Elkady, E. F.; Mowaka, S.; Attallah, M. A.; J. AOAC. Int. 2017, 100, 992–9. https://doi.org/10.5740/jaoacint.16-0279.
  • 21. Courlet, P.; Spaggiari, D.; Desfontaine, V.; Cavassini, M.; Alves Saldanha, S.; Buclin,T.; Marzolini, C.; Csajka, C.; Decosterd, L.A. J. Chromatogr. B. 2019, 1125, 121733. https://doi.org/10.1016/j.jchromb.2019.121733.
  • 22. Kasagić-Vujanović, I. ; Jančić-Stojanović, B. J. Pharm. Biomed. Anal. 2019, 173, 86–95. https://doi.org/10.1016/j.jpba.2019.05.026.
  • 23. Derringer, G.; Suich, R. J. Qual. Technol. 1980, 12, 214–9. https:// doi.org/10.1080/00224065.1980.11980968.
  • 24. Malenović, A. ; Dotsikas, Y. ; Mašković, M. ; Jančić-Stojanović, B. ; Ivanović, D. ; Medenica, M. Microchem. J. 2011, 99, 454–460. https://doi.org/10.1016/j.microc.2011.06.022.
  • 25. Vander Heyden, Y.; Nijhuis, A.; Smeyers-Verbeke, J.; Vandeginste, B.; Massart, D. J. Pharm. Biomed. Anal. 2001, 24, 723–53. https://doi.org/10.1016/S0731-7085(00)00529-X. Open Access.
Uwagi
Opracowanie rekordu ze środków MEiN, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2022-2023).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-0983b7c0-164f-41df-acd2-05c229a61220
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.